Clinical Trials Directory

Trials / Completed

CompletedNCT01170377

Effect of Valproate on Propofol

The Effect of Valproate on the Required Dose of Propofol for Sedation in Patients With Mental Retardation

Status
Completed
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Okayama University · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to evaluate the effect of valproate on the required dose of propofol for sedation in patients with mental retardation.

Detailed description

The intravenous sedation with propofol is very useful for patients with mental retardation and challenging behavior. However, it is very difficult to titrate the dose of propofol for maintaining the adequate sedation depth because of the difficulty of verbal communication with them. Most of them have a epilepsy and take antiepileptic drugs. Antiepileptic drugs are thought to influence on the effect of anesthetics. Valproate is reported to inhibit the metabolism of propofol. Therefore, we divide the patients into two groups : patients receiving valproate (valproate group), patients receiving no antiepileptic drugs (control group), and compare the required dose of propofol and the recovery time.

Conditions

Timeline

Start date
2007-04-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2010-07-27
Last updated
2015-10-21

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01170377. Inclusion in this directory is not an endorsement.